{"entity":{"type":"insider","cik":"0001824774","url":"/insider/0001824774","json_url":"/insider/0001824774.json","name":"Consonance Life Sciences","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":4,"first":"2020-11-25","last":"2022-12-15","span_basis":"filed_date"},"name_variants":[{"name":"Consonance Life Sciences","source":"filing","n_filings":4,"first_seen":"2020-11-25","last_seen":"2022-12-15"}],"transactions":[{"id":6118331,"accession":"0000899243-22-038571","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-22-038571","line_url":"/filing/0000899243-22-038571#line-4","is_derivative":false,"issuer_cik":"0001097955","issuer_name":"Surrozen, Inc./DE","issuer_ticker":"SRZN","issuer_name_source":null,"issuer_url":"/issuer/0001097955","owner_cik":null,"owner_name":"Consonance Capital Management LP; Livingston Kevin Harold; Soffer Benny; BLUTT MITCHELL J MD; Consonance Life Sciences; Consonance Capman GP, LLC","owner_display_name":"Consonance Capital Management LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1885000.0,"shares_display":"1,885,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-14","filed_date":"2022-12-15","scope":"insider"},{"id":6118328,"accession":"0000899243-22-038571","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-038571","line_url":"/filing/0000899243-22-038571#line-3","is_derivative":false,"issuer_cik":"0001097955","issuer_name":"Surrozen, Inc./DE","issuer_ticker":"SRZN","issuer_name_source":null,"issuer_url":"/issuer/0001097955","owner_cik":null,"owner_name":"Consonance Capital Management LP; Livingston Kevin Harold; Soffer Benny; BLUTT MITCHELL J MD; Consonance Life Sciences; Consonance Capman GP, LLC","owner_display_name":"Consonance Capital Management LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1748750.0,"shares_display":"1,748,750","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-14","filed_date":"2022-12-15","scope":"insider"},{"id":6118325,"accession":"0000899243-22-038571","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-038571","line_url":"/filing/0000899243-22-038571#line-2","is_derivative":false,"issuer_cik":"0001097955","issuer_name":"Surrozen, Inc./DE","issuer_ticker":"SRZN","issuer_name_source":null,"issuer_url":"/issuer/0001097955","owner_cik":null,"owner_name":"Consonance Capital Management LP; Livingston Kevin Harold; Soffer Benny; BLUTT MITCHELL J MD; Consonance Life Sciences; Consonance Capman GP, LLC","owner_display_name":"Consonance Capital Management LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1297922.0,"shares_display":"1,297,922","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-14","filed_date":"2022-12-15","scope":"insider"},{"id":6118322,"accession":"0000899243-22-038571","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-038571","line_url":"/filing/0000899243-22-038571#line-1","is_derivative":false,"issuer_cik":"0001097955","issuer_name":"Surrozen, Inc./DE","issuer_ticker":"SRZN","issuer_name_source":null,"issuer_url":"/issuer/0001097955","owner_cik":null,"owner_name":"Consonance Capital Management LP; Livingston Kevin Harold; Soffer Benny; BLUTT MITCHELL J MD; Consonance Life Sciences; Consonance Capman GP, LLC","owner_display_name":"Consonance Capital Management LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":450827.0,"shares_display":"450,827","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-14","filed_date":"2022-12-15","scope":"insider"},{"id":3080814,"accession":"0001104659-20-131773","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-131773","line_url":"/filing/0001104659-20-131773#line-1","is_derivative":false,"issuer_cik":"0001824774","issuer_name":"Consonance-HFW Acquisition Corp.","issuer_ticker":"CHFW","issuer_name_source":null,"issuer_url":"/issuer/0001824774","owner_cik":"0001824774","owner_name":"Consonance Life Sciences","owner_display_name":"Consonance Life Sciences","owner_url":"/insider/0001824774","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":24000.0,"shares_display":"24,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":434000.0,"shares_owned_after_display":"434,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-01","filed_date":"2020-12-03","scope":"insider"},{"id":2695430,"accession":"0001104659-20-129499","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-129499","line_url":"/filing/0001104659-20-129499#line-1","is_derivative":false,"issuer_cik":"0001824774","issuer_name":"Consonance-HFW Acquisition Corp.","issuer_ticker":"CHFW","issuer_name_source":null,"issuer_url":"/issuer/0001824774","owner_cik":"0001824774","owner_name":"Consonance Life Sciences","owner_display_name":"Consonance Life Sciences","owner_url":"/insider/0001824774","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":410000.0,"shares_display":"410,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":410000.0,"shares_owned_after_display":"410,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-23","filed_date":"2020-11-25","scope":"insider"},{"id":9204925,"accession":"0000899243-21-019997","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-019997","line_url":"/filing/0000899243-21-019997","is_derivative":false,"issuer_cik":"0001824774","issuer_name":"Consonance-HFW Acquisition Corp.","issuer_ticker":"CHFW","issuer_name_source":null,"issuer_url":"/issuer/0001824774","owner_cik":"0001824774","owner_name":"Consonance Life Sciences","owner_display_name":"Consonance Life Sciences","owner_url":"/insider/0001824774","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class B Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":90000.0,"shares_display":"90,000","price_per_share":0.0109,"price_display":"0.01","price_state":"stated","total_value":981.0,"total_display":"981.00","total_whole":"981","shares_owned_after":2270000.0,"shares_owned_after_display":"2,270,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-18","filed_date":"2021-05-19","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001824893","name":"Surrozen, Inc./DE","url":"/issuer/0001824893","role":"Director, Ten percent owner","n_filings":4,"first_seen":"2020-11-25","last_seen":"2022-12-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001824774","retrieved_at":"2026-08-23T19:45:06+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}